ARS Pharmaceuticals, Inc. (SPRY) short interest & options flow
NASDAQSPRY posted a 6% gain on the week to $6.30, but the real story is what's happening in the lending market — short interest remains near 22% of the free float, borrow availability is close to fully used, and the stock fell 6.6% the day after its most recent earnings print. The borrow picture is the sharpest signal right now. Availability has tightened dramatically over the past 30…
SPRY utilization hits 98.94%, near 52-week high of 100%, as shares available to borrow remain critically scarce at just 6.4% of short interest.
- Market cap
- $317M
- Next earnings
- 9 Mar 2027
Key data as of 10 Nov 2026
Latest signals on SPRY
- Utilization
SPRY utilization hits 98.94%, near 52-week high of 100%, as shares available to borrow remain critically scarce at just 6.4% of short interest.
SPRY news and analysis
RSSNo long-form analysis yet for SPRY. Pulse alerts and the live data picture are available on ORTEX.
Open SPRY on ORTEX →Want the live picture for SPRY?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for SPRY — free to start on ORTEX.
Sign up for free →Open SPRY on ORTEX